Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study

  • Authors:
    • Jin-Biao Chen
    • Rong Tang
    • Yong Zhong
    • Ya-Ou Zhou
    • Xiaoxia Zuo
    • Hui Luo
    • Li Huang
    • Wei Lin
    • Ting Wu
    • Yingqiang Yang
    • Ting Meng
    • Zhou Xiao
    • Xiang Ao
    • Xiangcheng Xiao
    • Qiaoling Zhou
    • Ping Xiao
  • View Affiliations / Copyright

    Affiliations: Department of Medical Records & Information, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 989
    |
    Published online on: July 13, 2021
       https://doi.org/10.3892/etm.2021.10421
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Chronic inflammation has been indicated to be important in the pathogenesis of anti‑neutrophil cytoplasmic antibody‑associated vasculitis (AAV). The systemic immune‑inflammation index (SII) is a novel marker of inflammation. The present study was thus performed to explore the association between the SII at diagnosis and inflammatory response and disease activity in Chinese patients with myeloperoxidase (MPO)‑AAV. Furthermore, it was evaluated whether the SII is able to predict the progression to end‑stage renal disease (ESRD) and patient survival. A total of 190 patients with MPO‑AAV were included in the present study. The baseline SII was positively correlated with C‑reactive protein (CRP; r=0.274, P<0.0001) and the erythrocyte sedimentation rate (ESR; r=0.481, P<0.0001). However, the SII had no obvious correlation with the Birmingham vasculitis activity score. Patients with SII≥2,136.45 exhibited better cumulative renal survival rates than those with SII<2,136.45 (P=0.001). However, no significant difference in patient survival was indicated between patients with SII≥2,136.45 and those with SII<2,136.45 at diagnosis. In conclusion, the SII was positively correlated with CRP and ESR in Chinese patients with MPO‑AAV. Furthermore, the SII may be an independent factor associated with a reduced risk of ESRD.
View Figures

Figure 1

Figure 2

View References

1 

Wu T, Peng J, Meng T, Liu Q, Ao X, Lin W, Yin H, Chen J, Pu J, Peng Z, et al: Clinicopathological features and prognostic analysis of 49 cases with crescentic glomerulonephritis. Exp Ther Med. 18:3984–3990. 2019.PubMed/NCBI View Article : Google Scholar

2 

Huang L, Zhong Y, Ooi JD, Zhou YO, Zuo X, Luo H, Chen JB, Wu T, Yang Y, Meng T, et al: The effect of pulse methylprednisolone induction therapy in Chinese patients with dialysis-dependent MPO-ANCA associated vasculitis. Int Immunopharmacol. 76(105883)2019.PubMed/NCBI View Article : Google Scholar

3 

Zhong Y, Pu J, Ao X, Peng W, Peng Z, Li X, Xiao X, Zhou Q and Xiao P: Investigation of status for vascular access in hemodialysis patients at Xiangya hospital of Central South university. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 42:1270–1274. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).

4 

Peng Z, Wang J, Yuan Q, Xiao X, Xu H, Xie Y, Wang W, Huang L, Zhong Y, Ao X, et al: Clinical features and CKD-related quality of life in patients with CKD G3a and CKD G3b in China: Results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol. 18(311)2017.PubMed/NCBI View Article : Google Scholar

5 

Goodnow CC: Multistep pathogenesis of autoimmune disease. Cell. 130:25–35. 2007.PubMed/NCBI View Article : Google Scholar

6 

Hutton HL, Alikhan MA and Kitching AR: Inflammasomes in the kidney. Exp Suppl. 108:177–210. 2018.PubMed/NCBI View Article : Google Scholar

7 

Hutton HL, Holdsworth SR and Kitching AR: ANCA-associated vasculitis: Pathogenesis, models, and preclinical testing. Semin Nephrol. 37:418–435. 2017.PubMed/NCBI View Article : Google Scholar

8 

Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J and Fan J: Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 20:6212–6222. 2014.PubMed/NCBI View Article : Google Scholar

9 

Yang R, Chang Q, Meng X, Gao N and Wang W: Prognostic value of systemic immune-inflammation index in cancer: A meta-analysis. J Cancer. 9:3295–3302. 2018.PubMed/NCBI View Article : Google Scholar

10 

de Joode AA, Sanders JS and Stegeman CA: Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 8:1709–1717. 2013.PubMed/NCBI View Article : Google Scholar

11 

Hilhorst M, van Paassen P and Tervaert JW: Limburg Renal Registry. Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA vasculitis. J Am Soc Nephrol. 26:2314–2327. 2015.PubMed/NCBI View Article : Google Scholar

12 

Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, et al: Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 367:214–223. 2012.PubMed/NCBI View Article : Google Scholar

13 

Li ZY, Ma TT, Chen M and Zhao MH: The prevalence and management of anti-neutrophil cytoplasmic antibody-associated vasculitis in China. Kidney Dis (Basel). 1:216–223. 2016.PubMed/NCBI View Article : Google Scholar

14 

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, et al: 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 65:1–11. 2013.PubMed/NCBI View Article : Google Scholar

15 

Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW and Scott D: Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 66:222–227. 2007.PubMed/NCBI View Article : Google Scholar

16 

Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, et al: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 17:2937–2944. 2006.PubMed/NCBI View Article : Google Scholar

17 

Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, et al: Modification and validation of the birmingham vasculitis activity score (version 3). Ann Rheum Dis. 68:1827–1832. 2009.PubMed/NCBI View Article : Google Scholar

18 

Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, et al: Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 21:1628–1636. 2010.PubMed/NCBI View Article : Google Scholar

19 

Chen YX, Xu J, Pan XX, Shen PY, Li X, Ren H, Chen XN, Ni LY, Zhang W and Chen N: Histopathological classification and renal outcome in patients with antineutrophil cytoplasmic antibodies-associated renal vasculitis: A study of 186 patients and metaanalysis. J Rheumatol. 44:304–313. 2017.PubMed/NCBI View Article : Google Scholar

20 

Chang DY, Li ZY, Chen M and Zhao MH: Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China. Semin Arthritis Rheum. 48:701–706. 2019.PubMed/NCBI View Article : Google Scholar

21 

Yuan Q, Wang J, Peng Z, Zhou Q, Xiao X, Xie Y, Wang W, Huang L, Tang W, Sun D, et al: Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). J Transl Med. 17(86)2019.PubMed/NCBI View Article : Google Scholar

22 

Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ and Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol. 167:39–45. 2005.PubMed/NCBI View Article : Google Scholar

23 

Xiao H, Hu P, Falk RJ and Jennette JC: Overview of the pathogenesis of ANCA-associated vasculitis. Kidney Dis (Basel). 1:205–215. 2016.PubMed/NCBI View Article : Google Scholar

24 

Ma TT, Huang YM, Wang C, Zhao MH and Chen M: Coagulation and fibrinolysis index profile in patients with ANCA-associated vasculitis. PLoS One. 9(e97843)2014.PubMed/NCBI View Article : Google Scholar

25 

Willeke P, Kumpers P, Schlüter B, Limani A, Becker H and Schotte H: Platelet counts as a biomarker in ANCA-associated vasculitis. Scand J Rheumatol. 44:302–308. 2015.PubMed/NCBI View Article : Google Scholar

26 

Budczies J, Klauschen F, Sinn BV, Győrffy B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff finder: A comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS One. 7(e51862)2012.PubMed/NCBI View Article : Google Scholar

27 

Kim Y, Choi H, Jung SM, Song JJ, Park YB and Lee SW: Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naive patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton). 24:711–717. 2018.PubMed/NCBI View Article : Google Scholar

28 

Basu N, Karabayas M and Pusey C: Prognosis and future developments in vasculitis. Best Pract Res Clin Rheumatol. 32:148–165. 2018.PubMed/NCBI View Article : Google Scholar

29 

Collecchi P, Baldini E, Giannessi P, Naccarato AG, Passoni A, Gardin G, Roncella M, Evangelista G, Bevilacqua G and Conte PF: Primary chemotherapy in locally advanced breast cancer (LABC): Effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers. Eur J Cancer. 34:1701–1704. 1998.PubMed/NCBI View Article : Google Scholar

30 

Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M and Evans J: Lupus Nephritis Collaborative Study Group. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int. 59:2156–2163. 2001.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen J, Tang R, Zhong Y, Zhou Y, Zuo X, Luo H, Huang L, Lin W, Wu T, Yang Y, Yang Y, et al: Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study. Exp Ther Med 22: 989, 2021.
APA
Chen, J., Tang, R., Zhong, Y., Zhou, Y., Zuo, X., Luo, H. ... Xiao, P. (2021). Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study. Experimental and Therapeutic Medicine, 22, 989. https://doi.org/10.3892/etm.2021.10421
MLA
Chen, J., Tang, R., Zhong, Y., Zhou, Y., Zuo, X., Luo, H., Huang, L., Lin, W., Wu, T., Yang, Y., Meng, T., Xiao, Z., Ao, X., Xiao, X., Zhou, Q., Xiao, P."Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study". Experimental and Therapeutic Medicine 22.3 (2021): 989.
Chicago
Chen, J., Tang, R., Zhong, Y., Zhou, Y., Zuo, X., Luo, H., Huang, L., Lin, W., Wu, T., Yang, Y., Meng, T., Xiao, Z., Ao, X., Xiao, X., Zhou, Q., Xiao, P."Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study". Experimental and Therapeutic Medicine 22, no. 3 (2021): 989. https://doi.org/10.3892/etm.2021.10421
Copy and paste a formatted citation
x
Spandidos Publications style
Chen J, Tang R, Zhong Y, Zhou Y, Zuo X, Luo H, Huang L, Lin W, Wu T, Yang Y, Yang Y, et al: Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study. Exp Ther Med 22: 989, 2021.
APA
Chen, J., Tang, R., Zhong, Y., Zhou, Y., Zuo, X., Luo, H. ... Xiao, P. (2021). Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study. Experimental and Therapeutic Medicine, 22, 989. https://doi.org/10.3892/etm.2021.10421
MLA
Chen, J., Tang, R., Zhong, Y., Zhou, Y., Zuo, X., Luo, H., Huang, L., Lin, W., Wu, T., Yang, Y., Meng, T., Xiao, Z., Ao, X., Xiao, X., Zhou, Q., Xiao, P."Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study". Experimental and Therapeutic Medicine 22.3 (2021): 989.
Chicago
Chen, J., Tang, R., Zhong, Y., Zhou, Y., Zuo, X., Luo, H., Huang, L., Lin, W., Wu, T., Yang, Y., Meng, T., Xiao, Z., Ao, X., Xiao, X., Zhou, Q., Xiao, P."Systemic immune‑inflammation index predicts a reduced risk of end‑stage renal disease in Chinese patients with myeloperoxidase‑anti‑neutrophil cytoplasmic antibody‑associated vasculitis: A retrospective observational study". Experimental and Therapeutic Medicine 22, no. 3 (2021): 989. https://doi.org/10.3892/etm.2021.10421
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team